Expert breaks down CLL frontline choices, IGHV and p53 risk, and what fits patient life. The treatment landscape for chronic lymphocytic leukemia (CLL) has undergone a seismic shift, moving from the ...
In a follow-up to the customs duty relief on essential medicines, the National Pharmaceutical Pricing Authority (NPPA) has directed manufacturers and marketing companies of the ...
After customs duty cuts on 17 cancer drugs, India’s price regulator ordered MRPs revised to pass on benefits, but activists say tax relief alone won’t make costly patented therapies affordable.
NPPA asks cos to revise prices of 17 drugs following BCD exemption: Gireesh Babu, New Delhi Thursday, February 12, 2026, 08:00 Hrs [IST] The National Pharmaceutical Pricing Author ...
Department of Health and Family Welfare, has issued a draft notification proposing further amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, introducing a structured regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results